Blood Journal
Leading the way in experimental and clinical research in hematology

All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol

  1. Martin S. Tallman,
  2. Janet W. Andersen,
  3. Charles A. Schiffer,
  4. Frederick R. Appelbaum,
  5. James H. Feusner,
  6. William G. Woods,
  7. Angela Ogden,
  8. Howard Weinstein,
  9. Lois Shepherd,
  10. Cheryl Willman,
  11. Clara D. Bloomfield,
  12. Jacob M. Rowe, and
  13. Peter H. Wiernik
  1. 1 From Northwestern University, Feinburg School of Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL (Eastern Cooperative Oncology Group [ECOG], Brookline, MA); Harvard School of Public Health, Boston, MA (ECOG); Karmanos Cancer Center, Wayne State University, Detroit, MI (Cancer and Leukemia Group B [CALGB], Chicago, IL); Fred Hutchinson Cancer Research Center, University of Washington, Seattle (Southwest Oncology Group [SWOG], San Antonio, TX); Children's Hospital of Northern California-Oakland; Emory University/ Children's Healthcare of Atlanta, GA; Texas Children's Cancer Center, Houston (Pediatric Oncology Group [POG], Chicago, IL); Massachusetts General Hospital, Harvard Medical School, Boston (POG); National Cancer Institute of Canada Clinical Trials Group, Kingston, ON; University of New Mexico, Albuquerque (SWOG); The Ohio State University, Columbus (CALGB); Rambam Medical Center, Technion, Haifa, Israel (ECOG); and Our Lady of Mercy Cancer Center, New York Medical College, Bronx (ECOG).

You do not have access to the full text of this article, the first page of the PDF of this article appears below.

PDF extract preview

To view this item, select one of the options below

If you already have a subscription, you may gain access using your ASH username and password.

Sign In for Institutional Administrators

If you are a Librarian or institutional account administrator you can use this link to manage your account and view usage reports.


Purchase Short-Term Access

Pay per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00.
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

OpenAthens Users

Log in through your institution

Sign Up

Subscribe to the Journal - Subscribe to the print and/or online journal.

Access for Patients

Access for Patients - Patients desiring access should contact the journal.